(855) 575-6376

2025 Peritoneal Mesothelioma Treatment Updates

Legally Reviewed by Joseph P. Williams on May 20, 2025

Patients with peritoneal mesothelioma now have more treatment options than ever before, with several promising therapies demonstrating improved survival rates in clinical trials. Recent advances in immunotherapy, targeted treatments, and surgical techniques are giving patients renewed hope in their fight against this aggressive cancer. You need accurate information about these treatment developments to make informed decisions about your care.

At The Williams Law Firm, P.C., we understand the challenges you face after a peritoneal mesothelioma diagnosis. Our team has spent decades representing asbestos victims and stays current with the latest medical advances to better serve our clients. With our extensive knowledge of asbestos-related diseases and treatment options, we can help you fight for your legal rights while you focus on your health.

Treatment Breakthroughs for Peritoneal Mesothelioma in 2025

The medical industry is always advancing and improving treatment techniques to provide the best possible quality of care to patients. Some of the peritoneal mesothelioma treatment updates so far in 2025 include the following:

Advancements in Multimodal Treatment Approaches

Peritoneal mesothelioma treatment has evolved significantly, with multimodal approaches showing the most promise. New developments include the following:

  • More precise surgical mapping techniques that help surgeons achieve complete cytoreduction more frequently.
  • Medical centers are optimizing HIPEC drug combinations and delivery methods to maximize effectiveness while reducing toxicity for patients.
  • Some medical centers now incorporate early postoperative intraperitoneal chemotherapy (EPIC) following HIPEC as an additional treatment layer. This approach delivers chemotherapy to the abdominal cavity during the critical days following surgery to target any remaining microscopic disease.

These multimodal treatment advancements are making waves for patients who may greatly benefit from these medical breakthroughs. If you or your family has been affected by mesothelioma due to asbestos exposure, understanding the options available for your health is important, but so is understanding the legal options available to help you secure the justice you deserve.

Immunotherapy Breakthroughs for Peritoneal Mesothelioma

Immunotherapy continues to transform the peritoneal mesothelioma treatment landscape in 2025. Several immune checkpoint inhibitors have shown promising results in clinical trials focused specifically on peritoneal mesothelioma patients. Pembrolizumab (Keytruda) and nivolumab (Opdivo), which target the PD-1 pathway, have demonstrated durable responses in some patients with peritoneal mesothelioma. 

New combination immunotherapy approaches are also showing promise. Dual checkpoint inhibition, combining PD-1 and CTLA-4 blockers, has demonstrated improved response rates compared to single-agent therapy in recent trials. Additionally, researchers are investigating novel combinations of immunotherapy with traditional treatments like chemotherapy and radiation.

CAR-T cell therapy, which engineers a patient’s own immune cells to recognize and attack cancer cells, is now in early-phase clinical trials for peritoneal mesothelioma. While still experimental, this approach has shown encouraging preliminary results in patients who failed to respond to other treatments.

Targeted and Precision Medicine Approaches

Precision medicine has opened new avenues for peritoneal mesothelioma treatment by identifying specific genetic alterations that can be targeted with specialized drugs. Genomic profiling is increasingly being used to guide treatment decisions. Some examples of this include the following:

  • BAP1: BAP1 mutations, found in approximately 60% of mesothelioma cases, are now being targeted with specific inhibitors in clinical trials. Patients with these mutations may qualify for specialized treatments that work by exploiting this genetic vulnerability.
  • PARP inhibitors: PARP inhibitors, which have shown success in other cancers with similar genetic profiles, are now being evaluated in mesothelioma patients with specific DNA repair defects. Early data suggests these drugs may be effective for a subset of peritoneal mesothelioma patients.
  • Anti-anogenic drugs: Anti-angiogenic drugs like bevacizumab (Avastin) are being incorporated into more treatment regimens based on evidence that they can enhance the effectiveness of standard chemotherapy. Studies show the addition of these drugs may improve progression-free survival by disrupting the blood supply to tumors.

All of these options can be groundbreaking treatments for patients dealing with peritoneal mesothelioma.

Innovative Clinical Trials and Emerging Therapies

Several groundbreaking clinical trials are offering peritoneal mesothelioma patients access to cutting-edge treatments not yet widely available. These studies include the following:

  • Tumor Treating Fields (TTFields)
  • Virotherapy
  • Dendritic cell vaccines

Researchers are also exploring new drug delivery systems to improve treatment efficacy. If you have been diagnosed with peritoneal mesothelioma, you have the right to file a claim to pursue compensation for your losses, such as those spent on costly medical treatments. To learn more about your legal options, contact our law firm today.

Contact The Williams Law Firm, P.C. for Legal Guidance

If you or someone you know has been diagnosed with peritoneal mesothelioma, understanding your legal options is crucial. The Williams Law Firm, P.C. has never lost a mesothelioma case and has recovered millions of dollars for our clients. Our team, led by Joseph P. Williams with over 30 years of experience, will fight for the compensation you deserve while you focus on your treatment.

We understand the complexities of asbestos exposure cases and will personally meet with you in your home to discuss your situation. Our firm handles your case as our cause, not just another file, providing personalized service throughout the legal process. Schedule a free consultation by calling (855) 575-6376 or visiting our contact form.

Joseph P. Williams

Legally Reviewed by

Joseph P. Williams
Renowned Mesothelioma Attorney

May 20, 2025

As the founding partner of Williams Law Firm, Joseph P. Williams has dedicated over 30 years to representing mesothelioma victims and their families. His firm has recovered hundreds of millions of dollars for those affected by asbestos exposure, offering personalized, aggressive legal advocacy. Based in New York, Williams Law Firm provides free consultations and handles cases nationwide.

Free consultation

  • This field is for validation purposes and should be left unchanged.
  • This field is for validation purposes and should be left unchanged.